Literature DB >> 7268190

Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.

J G Wagner, A R DiSanto, W R Gillespie, K S Albert.   

Abstract

The simplest three pharmacokinetic models which apply in cases of reversible metabolism are described. Area under the curve (AUC) relationships are described which allow one to make a choice of which one of the three models may apply in a particular case. Expressions for clearances and other pharmacokinetic parameters are given. It is shown that biexponential time courses are expected after bolus intravenous administration although distribution is not involved in the models. In some cases dose/AUC or infusion rate/steady-state concentration yield simple clearances, while in other cases they are complex. AUC data obtained following oral administration of 5 mg doses of prednisone and prednisolone to 16 normal volunteers were analyzed with the new concepts and one of the models was found to apply. This new interpretation of such data results in some significant changes from application of classical pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7268190

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  12 in total

1.  Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

2.  Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 3.  Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

4.  Comparative study of availability of prednisolone after intestinal infusion of prednisolone metasulfobenzoate and prednisone.

Authors:  C Rollin; O Chosidow; B Diquet; C Dutreuil; S Herson; J Revuz; J C Delchier
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.

Authors:  G M Pollack; K L Brouwer
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

6.  Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.

Authors:  Thomayant Prueksaritanont; Yue Qiu; Lillian Mu; Kimberly Michel; Janice Brunner; Karen M Richards; Jiunn H Lin
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

7.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man.

Authors:  H Bechtold; D Trenk; T Meinertz; M Rowland; E Jähnchen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.

Authors:  W F Ebling; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

10.  Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits. I. Single-dose study.

Authors:  W A Ritschel
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.